It’s the penultimate episode of Road to 30 Years. Today, we’re at the World Trade Center’s Oculus discussing how the agency’s relationship with private equity has evolved in tandem with PE’s increased interest in the life science industry. Check out the full journey on www.pharmasalmanac.com.

Update cookies preferences